Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaoli Song

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
Med (New York, N.Y.)|August 16, 2024
Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancerJian Pan, Junlong Wu, Beihe Wang, et al.
International Journal of Surgery (London, England)|November 13, 2025
A prospective single-center cohort study: integrating PET imaging and genomics to identify early biomarkers of response to dual-targeted PH neoadjuvant therapy in breast cancerBenlong Yang, Ming Chen, Panli Li, et al.
Physics in Medicine and Biology|July 10, 2025
Texture features-guided image reconstruction kernel method for<sup>18</sup>F-FDG delayed PET imagingZhichao Song, Jianping Zhang, Zixiang Chen, et al.
Molecular Oncology|October 9, 2022
The prevalence and prognosis of next-generation therapeutic targets in metastatic castration-resistant prostate cancerJian Pan, Jinou Zhao, Xudong Ni, et al.
International Journal of Cancer|May 1, 2018
The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI-microangiography-histopathology in ratsYewei Liu, Frederik De Keyzer, Yixin Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2023
Heterogeneity of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in metastatic castration-resistant prostate cancer: genomic characteristics and association with abiraterone responseJian Pan, Jinou Zhao, Xudong Ni, et al.
The Journal of Clinical Investigation|January 4, 2024
68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancerKe Li, Wei Liu, Hang Yu, et al.
Bioconjugate Chemistry|July 2, 2024
Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular ScaffoldLei Li, Rui Cao, Kaixin Chen, et al.
Quantitative Imaging in Medicine and Surgery|December 19, 2015
Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic researchYewei Liu, Ting Yin, Yuanbo Feng, et al.
The Journal of Clinical Investigation|April 15, 2024
68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancerKe Li, Wei Liu, Hang Yu, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
Med (New York, N.Y.)|August 16, 2024
Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancerJian Pan, Junlong Wu, Beihe Wang, et al.
International Journal of Surgery (London, England)|November 13, 2025
A prospective single-center cohort study: integrating PET imaging and genomics to identify early biomarkers of response to dual-targeted PH neoadjuvant therapy in breast cancerBenlong Yang, Ming Chen, Panli Li, et al.
Physics in Medicine and Biology|July 10, 2025
Texture features-guided image reconstruction kernel method for<sup>18</sup>F-FDG delayed PET imagingZhichao Song, Jianping Zhang, Zixiang Chen, et al.
Molecular Oncology|October 9, 2022
The prevalence and prognosis of next-generation therapeutic targets in metastatic castration-resistant prostate cancerJian Pan, Jinou Zhao, Xudong Ni, et al.
International Journal of Cancer|May 1, 2018
The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI-microangiography-histopathology in ratsYewei Liu, Frederik De Keyzer, Yixin Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2023
Heterogeneity of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in metastatic castration-resistant prostate cancer: genomic characteristics and association with abiraterone responseJian Pan, Jinou Zhao, Xudong Ni, et al.
The Journal of Clinical Investigation|January 4, 2024
68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancerKe Li, Wei Liu, Hang Yu, et al.
Bioconjugate Chemistry|July 2, 2024
Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular ScaffoldLei Li, Rui Cao, Kaixin Chen, et al.
Quantitative Imaging in Medicine and Surgery|December 19, 2015
Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic researchYewei Liu, Ting Yin, Yuanbo Feng, et al.
The Journal of Clinical Investigation|April 15, 2024
68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancerKe Li, Wei Liu, Hang Yu, et al.
Pageof 25